rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2010-12-8
|
pubmed:abstractText |
potential epigenetic biomarkers for malignant transformation to carcinoma ex pleomorphic adenoma (Ca ex PSA) have been sought previously with and without specific comparison with the benign variant, pleomorphic salivary adenoma (PSA). Previous analysis has been limited by a non-quantitative approach. We sought to demonstrate quantitative promoter methylation across a panel of tumour suppressor genes (TSGs) in both Ca ex PSA and PSA.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1532-1827
|
pubmed:author |
|
pubmed:copyrightInfo |
2010 Cancer Resaerch UK.
|
pubmed:issnType |
Electronic
|
pubmed:day |
7
|
pubmed:volume |
103
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1846-51
|
pubmed:dateRevised |
2011-2-8
|
pubmed:meshHeading |
pubmed-meshheading:21063414-Adenoma, Pleomorphic,
pubmed-meshheading:21063414-DNA Methylation,
pubmed-meshheading:21063414-Genes, Tumor Suppressor,
pubmed-meshheading:21063414-Humans,
pubmed-meshheading:21063414-Membrane Proteins,
pubmed-meshheading:21063414-Neoplasm Proteins,
pubmed-meshheading:21063414-Polymerase Chain Reaction,
pubmed-meshheading:21063414-Promoter Regions, Genetic,
pubmed-meshheading:21063414-Salivary Gland Neoplasms,
pubmed-meshheading:21063414-Telomerase,
pubmed-meshheading:21063414-WT1 Proteins
|
pubmed:year |
2010
|
pubmed:articleTitle |
Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma.
|
pubmed:affiliation |
Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Daulby Street, Liverpool L69 3GN, UK. schache@liverpool.ac.uk
|
pubmed:publicationType |
Journal Article
|